Abstract
This chapter entitled “Immune System, Redox Signaling, and Cancer Immunity” starts with the characteristics of various immune systems (innate and adaptive) and immune cells, and their association with cancer cells. Dysfunction of the role of immune systems in diseases has been discussed. The role of ROS and redox regulation in immune system activity through the activation and deactivation of various immune cells has been taken up extensively.
Furthermore, the link between immunity and anticancer strategies has been discussed. Various experimental models to exhibit the interaction of immune cells and also TME cells in various tumor models have been discussed, which provide information on the activation or suppression of immune cells which further may be useful in translating into immunotherapy. In simple terms, cancer cell genomic instability provides neo-antigen, which suppresses the T cell function through the generation of inhibitory molecules such as popular CTLA-4 and PD-1, which were exploited for cancer therapy. The role of TME cells in immune responses to cancer cells has also been taken up. Also, immune metabolism (interplay between immunologic and metabolic processes) where immune system mediates cancer initiation and development has been discussed. Cell intrinsic metabolism directly controls the effector function and cellular fate. Interestingly, suppressed immune activity in an increased ROS situation in the TME was addressed by using nanomaterials to suppress ROS levels and, in turn, enhance immune response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal B (2019) New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota. Clin Trans Med 8:23. 13 pages
Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley et al (2009) Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114:1537–1544
Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di Trapani G et al (2002) Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A 99:1491–1496
Antonio N, Bonnelykke ML, Ward LC, Collin J, Christensen IJ et al (2015) The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J 34:2219–2236
Aras S, Zaidi MR (2017) Tameless traitors: macrophages in cancer progression and metastasis. Br J Cancer 117:1583–1591
Aurelius J, Thoren FB, Akhiani AA, Brune M, Palmqvist L et al (2012) Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis. Blood 119:5832–5837
Aurelius J, Hallner A, Werlenius O, Riise R, Mollgard L et al (2017) NOX2-dependent immunosuppression in chronic myelomonocytic leukemia. J Leukoc Biol 102:459–466
Aydin E, Johansson J, Nazir FH, Hellstrand K, Martner A (2017) Role of nox2-derived reactive oxygen species in NK cell-mediated control of murine melanoma metastasis. Cancer Immunol Res 5:804–811
Bai A, Moss A, Rothweiler S, Serena Longhi M, Wu Y, Junger WG et al (2015) NADH oxidase-dependent cd39 expression by cd8(+) e cells modulates interferon gamma responses via generation of adenosine. Nat Commun 6:8819. 12 pages
Baker MP, Reynolds HM, Lumicisi B, Bryson CJ (2010) Immunogenicity of protein therapeutics: the key causes, consequences and challenges. Self Nonself 1:314–322
Baras AS, Drake C, Liu JJ, Gandhi N, Kates M et al (2016) The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder. Oncoimmunology 5:e1134412
Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I et al (2009) IL-1 acts directly on cd4 t cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A 106:7119–7124
Biswas SK (2015) Metabolic reprogramming of immune cells in cancer progression. Immunity 43:435–449
Boveris A (1977) Mitochondrial production of superoxide radical and hydrogen peroxide. Adv Exp Med Biol 78:67–82
Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A et al (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24:657–671
Brodsky M, Halpert G, Albeck M, Sredni B (2010) The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFkappaB signaling pathway and nitric oxide induction in macrophages. J Inflamm 7:3. 8 pages
Brune M, Castaigne S, Catalano J, Gehlsen K, Ho AD et al (2006) Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial. Blood 108:88–96
Calcinotto A, Filipazzi P, Grioni G, Iero M, De Milito A et al (2012) Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res 72:2746–2756
Castellani P, Angelini G, Delfino L, Matucci A, Rubartelli A (2008) The thiol redox state of lymphoid organs is modified by immunization: role of different immune cell populations. Eur J Immunol 38:2419–2425
Cathro HP, Smolkin ME, Theodorescu D, Jo VY, Ferrone S, Frierson HF Jr (2010) Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. Cancer Immunol Immunother 59:465–472
Cervantes-Villagrana RD, Albores-Garcia D, Cervantes-Villagrana AR, Garcia-Acevez SJ (2020) Tumor-induced neurogenesis and immune evasion as targets of innovative anticancer therapies. Signal Transduct Target Ther 5:99. 23 pages
Chamoto K, Chowdhury PS, Kumar A, Sonomura K, Matsuda F, Fagarasan S et al (2017) Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci U S A 114:E761–E770
Chavez-Galan L, Angel MCAD, Zenteno E, Chavez R, Lascuram R (2009) Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 6:15–25
Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227–242
Chen X, Song M, Zhang B, Zhang Y (2016) Reactive oxygen species regulate T cell immune response in the tumor microenvironment. Oxid Med Cell Longav 2016:1580967, 10 pages
Chen ZH, Qiu M, Wu X, Wu Q, Lu J et al (2018) Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients. J Cancer 9:512–520
Cohen MS, Ryan JL, Root RK (1981) The oxidative metabolism of thioglycollate-elicited mouse peritoneal macrophages: the relationship between oxygen, superoxide and hydrogen peroxide and the effect of monolayer formation. J Immunol 127:1007–1011
Colegio OR, Chu N-Q, Szabo AL, Chu T, Rhebergen AM, Jairam V et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513:559–563
Comito G, Giannoni CP, Segura CP, Barcellos-de-Souza P, Raspollini MR et al (2014) Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene 33:2423–2431
Corzo CA, Cotter MJ, Cheng PY, Cheng FD, Kusmartsev S, Sotomayor E et al (2009) Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 182:5693–5701
Coussens LM, Werb Z (2003) Inflammation and cancer. Nature 420:860–867
Curtsinger JM, Mescher MF (2010) Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 22:333–340
Dai J, Fang P, Saredy J, ** H, Ramon C, Yang W et al (2017) Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated cd40(+) monocyte differentiation. J Hematol Oncol 10:141. 18 pages
Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers of oxidative damage in human disease. Clin Chem 52:601–623
Dandekar RC, Kingaonkar AV, Dhabekar GS (2011) Role of macrophages in malignancy. Ann Maxillofac Surg 1:150–154
DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19:369–382
Deng H, Yang W, Zhou Z, Tian R, Lin L, Ma Y et al (2020) Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death. Nat Commun 11:4951. 12 pages
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F et al (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793–800
Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune activation through nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677
Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of cd40/ed401 engagement in the immune system. Immunol Rev 229:152–172
El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kundo M, Hsu C et al (2017) Nivolumab in patients with advanced hepatocellular carcinoma(CheckMate 040): an open-label, non-comparative, phase ½ dose escalation and expansion trial. Lancet 389:2492–2502
Engblom C, Pfirschke C, Pittet MJ (2016) The role of myeloid cells in cancer therapies. Nat Rev Cancer 16:447–462
Enukidze M, Machavariani MG, Intskirveli NA, Bezhitashvili ND, Sanikidze TV et al (2009) Cell death in Jurkat cells induced by oxygen/nitrogen stress. Georgian Med News 167:109–113
Evans MK, Sauer SJ, Nath S, Robinson TJ, Morse MA, Devi GR (2016) X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity. Cell Death Dis 7:e2073
Fallarino F, Grohmann U, Puccetti P (2012) Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur J Immunol 42:1932–1937
Fan MY, Turka LA (2018) Immunometabolism and PI(3)K signaling as a link between IL-2, Foxp3 expression, and suppressor function in regulatory T cells. Front Immunol 9:69
Fang PU, Li X, Dai J, Cole L, Camacho JA, Zhang Y, Ji Y, Wang J, Yang XF, Wang H (2018) Immune cell subset differentiation and tissue inflammation. J Hematol Oncol 11:97. 22 pages
Feng M, Chen JY, Weissman-Tsukamoto R, Volkmer JP et al (2015) Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk. Proc Natl Acad Sci U S A 112:2145–2150
Feng J, Lu S, Ding Y, Zheng M, Wang X (2016) Homocysteine activates t cells by enhancing endoplasmic reticulum-mitochondria coupling and increasing mitochondrial respiration. Protein Cell 7:391–402
Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y, Shimada M (2018) Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction. Cell Commun Signal 16:54
Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, Packer L (1997) Redox regulation of NF-kappa B activation. Free Radic Biol Med 22:1115–1126
Flower DR, Doytchinova IA (2002) Immunoformatics and the prediction of immunogenicity. Appl Bioinforma 1:167–176
Franchina DG, Dostert C, Brenner D (2018) Reactive oxygen species: involvement in t cell signaling and metabolism. Trends Immunol 39:489–502
Freemerman AJ, Johnson AR, Sacks GN, Milner JJ, Kirk EL et al (2014) Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem 289:7884–7896
Fridlender ZG, Sun J, Kim S, Kapoor VK, Cheng G et al (2013) Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16:183–194
Frossi B, De Carli M, Piemonte M, Pucillo C (2008) Oxidative microenvironment exerts an opposite regulatory effect on cytokine production by th1 and th2 cells. Mol Immunol 45:58–64
Frumento G, Piazza T, Di Carlo E, Ferrini S (2006) Targeting tumor-related immunosuppression for cancer immunotherapy. Endocr Metab Immune Disord Drug Targets 6:233–237
Fuchs D, Baier-Bitterlich G, Wede I, Wachter H (1997) Reactive oxygen and apoptosis. In: Scandalios JG (ed) Oxidative stress and the molecular biology of antioxidant defences. Cold Spring Habor Laboratory Press, Cold Spring Habor, New York, pp 139–167
Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162–174
Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S (2013) Tumor associated macrophages and neutrophils in cancer. Immuno Biol 218:1402–1410
Gelloni M, Zanetti M (2005) CD4 T cells in tumor immunity. Springer Semin Immunopathol 27:37–48
Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D et al (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21:938–945
Gerner MY, Heltemes-Harris LM, Fife BT, Mescer MF (1950) Cutting edge: i1-12 and type I ifn differentially program cd8 t cells for programmed death 1 re-expression levels and tumor control. J Immunol 191:1011–1015
Ghosh S, Mukherjee S, Choudhury S, Gupta P, Adhikary A, Baral R et al (2015) Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: role of fluoxetine. Cell Signal 27:1398–1412
Gostner JM, Becker K, Fuchs D, Sucher R (2013) Redox regulation of the immune response. Redox Rep 18:88–94
Goulopoulou S, McCarthy CG, Webb RC (2016) Toll-like receptors in the vascular system: sensing the dangers within. Pharmacol Rev 68:142–167
Green DR, Droin N, Pinkoski M (2003) Activation-induced cell death in t cells. Immunol Rev 193:70–81
Griffiths HR, Gao D, Pararasa C (2017) Redox regulation in metabolic programming and inflammation. Redox Biol 12:50–57
Gropper Y, Feferman T, Shalit T, Salame TM, Porat Z, Shakhar G (2017) Culturing CTLs under hypoxic conditions enhances their cytolysis and improves their anti-tumor function. Cell Rep 20:2547–2555
Guevara-Patino JA, Turk MJ, Wolchok JD, Houghton AN (2003) Immunity to cancer through immune recognition of altered self: studies with melanoma. Adv Cancer Res 90:157–177
Gun SY, Lee SWL, Sieow JL, Wong SC (2019) Targeting immune cells for cancer therapy. Redox Biol 25:101174. 16 pages
Gunderson AJ, Kaneda MM, Tsujikawa T, Nguyen AV, Affara NI et al (2016) Bruton tyrosine kinase-dependent immune cell cross-talk drives pancreas cancer. Cancer Discov 6:270–285
Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN et al (2008) HLA class I antigen processing machinery component expression and intra tumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res 14:3372–3379
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hasan AA, Ghaemmaghami AM, Fairclough L, Robins A, Sewell HF, Shakib F (2009) Allergen-driven suppression of thiol production by human dendritic cells and the effect of thiols on T cell function. Immuno Biol 214:2–16
Hashimoto O, Yoshida M, Koma YI, Yanai T, Hasegawa D et al (2016) Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development. J Pathol 240:211–223
Hayakawa Y, Smyth MJ (2006) Innate immune recognition and suppression of tumors. (Adv P) cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Inves 125:3335–3337
Hegedus C, Kovacs K, Polgar Z, Regdon Z, Szabo E, Robaszkiewicz A, Forman HJ, Martner A, Virag L (2018) Redox control of cancer cell destruction. Redox Biol 16:59–74
Hervera A, De Virgiliis F, Palmisaano I, Zhou L, Tantardini E et al (2018) Reactive oxygen species regulate axonal regeneration through the release of exosomal NADPH oxidase 2 complexes into injured axons. Nat Cell Biol 20:307–319
Ho PC, Bihuniak JD, Macintyre AN, Staron M, Liu X et al (2015) Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162:1217–1228
Hoffmann G, Schobersberger W, Frede S, Pelzer L, Fandrey J, Wachter H et al (1996) Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells. FEBS Lett 391:181–184
Hoves S, Trapani JA, Voskoboinik I (2010) The battlefield of perforin/granzyme cell death pathways. J Leukoc Biol 87:237–243
Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG (2016) Genomic analysis of immune cell infiltrates across 11 tumor types. J Natl Cancer Inst 108:djw144. 11 pages
Iwasaki A, Medzhitov R (2015) Control of adaptive immunity by the innate immune system. Nat Immunol 16:343–353
Jaganjac M, Milkovic L, Sunjic SB, Zarkovic N (2020) The Nrf2, thioredoxin and glutathione system in tumorigenesis and anticancer therapies. Antioxidants 9:1151
Jain A, Pasare C (1950) Innate control of adaptive immunity: beyond the three-signal paradigm. J Immunol 198:3791–3800
Jang JE (2017) Crosstalk between regulatory T cells and tumor-associated dendritic cells negates anti-tumor immunity in pancreatic cancer. Cell Rep 20:558–571
Jounai N, Kobiyama K, Takeshita F, Ishii KJ (2013) Recognition of damage-associated, nucleic acid-related molecular patterns during inflammation and vaccination. Front Cell Infect Microbiol 2:168. 13 pages
Kaminski MM, Sauer SW, Klemke CD, Suss D, Okun JG, Krammer PH et al (1950) Mitochondrial reactive oxygen species control t cell activation by regulatine il-2 and il-4 expression: mechanism of ciprofloxacin-mediated immunosuppression. J Immunol 184:4827–4841
Kanduc D (2019) From hepatitis C virus immunoproteomics to rheumatology via cross-reactivity in one table. Curr Opin Reheumatol 31:488–492
Karin M (2009) NF-κB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1:a000141. 14 pages
Kelkka T, Pizzolla A, Laurila JP, Friman T, Gustafsson R et al (2013) Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. PLoS One 8:e84148
Kesarwani P, Murali AK, Al-Khami AA, Mehrotra S (2013) Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 18:1497–1534
Kim YH, Kumar A, Chang CH, Pyaram K (1950) Reactive oxygen species regulate the inflammatory function of nkt cells through promyelocytic leukemia zinc finger. J Immunol 199:3478–3487
Kim HD, Song GW, Park S, Jung MK, Kim MH, Kang HJ et al (2018) Association between expression level of PD1 by tumor-infiltrating CD8+ T cells and features of hepatocellular carcinoma. Gastroenterol 155:1936–1950
Kitamura T, Qian BZ, Pollard JW (2015) Immune cell promotion of metastasis. Nat Rev Immunol 15:73–86
Kojima Y, Kawasaki-Koyanagi A, Sueyoshi N, Kanai A, Yogita H, Okumura K (2002) Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity. Biochem Biophys Res Commun 296:328–336
Komohara Y, **ushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105:1–8
Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM et al (2010) Induction of regulatory t cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 107:17686–17691
Kratky W, Reis E, Sousa C, Oxenius A, Sporri R (2011) Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination. Proc Natl Acad Sci U S A 108:17414–17419
Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 206:1327–1337
Lendeckel U, Wolke C (2022) Redox-Regulation in cancer stem cells. Biomedicine 10:2413
Lendeckel U, Venz S, Wolke C (2022) Macrophages: shapes and functions. Chem Texts 8:12
Ligtenberg MA, Cinar O, Holmdahl R, Mougiakakos D, Kiessling R (2015) Methylcholenthrene induced sarcomas develop independently from NOX2-derived ROS. PLoS One 10:e0129786
Lin X, Zheng W, Liu J, Zhang Y, Qin H, Wu H et al (2013) Oxidative stress in malignant melanoma enhances tumor necrosis factor-alpha secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal 19:1337–1355
Lin CY, Wang WH, Chen SH, Chang YW, Hung LC et al (2017) Lipopolysaccharide-induced nitric oxide, prostaglandin E2, and cytokine production of mouse and human macrophages are suppressed by pheophytin-b. Int J Mol Sci 18:2637. 14 pages
Liou GY, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44:479–496
Liu F, Lang R, Zhao J, Zhang X, Pringle GA et al (2011) CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat 130:645–655
Liu R, Cao J, Gao X, Zhang J, Wang L et al (2016) Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L. Tumour Biol 37:14083–14088
Los M, Schenk H, Hexel K, Baeuerle PA, Dröge W, Schulze-Osthoff K (1995) IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 14:3731–3740
Maj T, Wang W, Crespo J, Zhang HJ, Wang WM, Wei S et al (2017) Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol 18:1332–1341
Marhelava K, Pilch Z, Bajor M, Graczyk-Jarzynka A, Zagozdzon R (2019) Targeting negative and positive immune checkpoints with monoclonal antibodies in therapy of cancer. Cancers 11:1756. 21 pages
Martner A, Aurelius J, Rydstrom A, Hellstrand K, Thoren FB (2011) Redox remodeling by dendritic cells protects antigen-specific T cells against oxidative stress. J Immunol 187:6243–6248
Martner A, Thoren FB, Aurelius J, Hellstrand K (2013) Immunotherapeutic strategies for relapse control in acute myeloid leukemia. Blood Rev 27:209–216
Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME et al (2003) Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 171:3010–3018
Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M et al (2018) Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med 378:439–448
McNally A, Hill GR, Sparwasser T, Thmas R, Steptoe RJ (2011) CD4(+) CD25(+) regulatory T cells control CD8(+) T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci U S A 108:7529–7534
Meng Y, Liang H, Hu J, Liu S, Hao X et al (2018) PD-L1 expression correlates with tumor infiltrating lymphocytes and response to neoadjuvant chemotherapy in cervical cancer. J Cancer 9:2938–2945
Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, Maclver NJ et al (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186:3299–3303
Mimura K, Kua LF, Shimasaki N, Shiraishi K, Nakajima S et al (2017) Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress. Cancer Immunol Immunother 66:605–613
Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219–230
Mocsai A (2013) Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med 210:1283–1299
Molnar E, Swamy M, Holzer M, Beck-Garcia K, Worch R, Thiele C et al (2012) Cholesterol and sphimgomyelin drive ligand-independent t-cell antigen receptor nanoclustering. J Biol Chem 287:42664–42674
Munder M (2009) Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 158:638–6351
Munn DH, Mellor AL (2013) Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 34:137–143
Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8:618–631
Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3:175–187
Nadimpalli SK, Amancha PK (2010) Evolution of mannose 6-phosphate receptors (MPR300 and 46): lysosomal enzyme sorting proteins. Curr Protein Pept Sci 11:68–90
Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S et al (2007) Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 13:828–835
Nathan CF, Murray HW, Wiebe ME, Rubin BY (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670–689
Natoli G, Ostuni R (2019) Adaptation and memory in immune responses. Nat Immunol 20:783–792
Netea-Maier RT, Smit JWA, Netea MG (2018) Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship. Cancer Lett 413:102–109
Niedbala W, Wei XQ, Piedrafita D, Xu D, Liew FY (1999) Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol 29:2498–2505
Niedbala W, Cai B, Liew FY (2006) Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis 65:37–40
Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ et al (2012) CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res 18:3281–3292
Oflazoglu E, Stone IJ, Brown L, Gordon KA, van Rooijen N et al (2009) Macrophages and Fc-receptor interactions contribute to the antitumor activities of the anti-CD40 antibody SGN-40. Br J Cancer 100:113–117
Ohl K, Tenbrock K (2018) Reactive oxygen species as regulators of MDSC-mediated immune suppression. Front Immunol 9:2499. 7 pages
Ohta A (2016) A metabolic immune checkpoint: adenosine in tumor microenvironment. Front Immunol 7:109. 11 pages
Oppenheim DE, Spreafico R, Etuk A, Malone D, Amofah E et al (2014) Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy. Br J Cancer 110:1221–1227
OuYang LY, Wu XJ, Ye SB, Zhang RX, Li ZL, Liao W et al (2015) Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer. J Transl Med 13:47. 12 pages
Pearce EL, Poffenberger MC, Chang CH, Jones RG (2013) Fueling immunity: insights into metabolism and lymphocyte function. Science 342:1242454. 30 pages
Penny HL, Sieow JL, Adriani G, Yeap WH, Ee PSC et al (2016) Warburg metabolism in tumors: macrophages promotes metastasis in human pancreatic ductal adenocarcinoma. Oncoimmunology 5:e1191731
Preston CC, Maurer MJ, Oberg AL, Visscher DW, Kalli KR et al (2013) The ratios of CD8+ T cells to CD4+ CD25+FOXP3+ and FOXP3-T cells correlate with poor clinical outcome in human serous ovarian cancer. PLoS One 8:e80063
Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39–51
Raghunath A, Sundarraj K, Nagarajan R, Arfuso F, Bian J, Kumar AP et al (2018) Antioxidant response elements: discovery, classes, regulation and potential applications. Redox Biol 17:297–314
Razumovitch JA, Semenkova GN, Fuchs D, Cherenkevich SN (2003) Influence of neopterin on the generation of reactive oxygen species in human neutrophils. FEBS Lett 549:83–86
Roche PA, Furuta K (2015) The ins and outs of mhc class ii-mediated antigen processing and presentation. Nat Rev Immunol 15:203–216
Rojo de la Vega M, Chapman E, Zhang DD (2018) Nrf2 and the hallmarks of cancer. Cancer Cell 34:21–43
Romero P, Cerottini JC, Speiser DE (2006) The human T cell response to melanoma antigens. Adv Immunol 92:187–224
Rubtsov AV, Rubtsova K, Kappler JW, Jacobelli J, Friedman RS, Marrack P (2015) CD11c-expressing B cells are located at the T cell/B cell border in spleen and are potent APCs. J Immunol 195:71–79
Ruf M, Moch H, Schraml P (2016) PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma. Int J Cancer 139:396–403
Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27:462–472
Saha S, Bhasin M, Raghava GP (2005) Bcipep: a database of B-cell epitopes. BMC Genomics 6:79. 7 pages
Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D (2010) Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50:1–14
Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10:490–500
Sarvaria A, Madrigal JA, Saudemont A (2017) B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol 14:662–674
Schar** NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC et al (2016) The tumor microenvironment represses T cell mitochondrial biogenesis to drive Intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45:374–388
Schildberg FA, Klein SR, Freeman GJ, Sharpe AH (2016) Coinhibitory pathways in the b7-cd28 ligand-receptor family. Immunity 44:955–972
Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 61:4756–4760
Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D (2006) Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364:82–90
Secrist JP, Burns LA, Karnitz L, Koretzky GA, Abraham RT (1993) Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J Biol Chem 268:5886–5893
Seliger B (2005) Strategies of tumor immune evasion. Bio Drugs 19:347–354
Shen H, Wu N, Nanayakkara G, Fu H, Yang Q, Yang WY et al (2019) Co-signaling receptors regulate t-cell plasticity and immune tolerance. Front Biosci 24:96–132
Shimizu K, Iyoda T, Okada M, Yamasaki S, Fujii SI (2018) Immune suppression and reversal of the suppressive tumor microenvironment. Int Immunol 30:445–455
Shimobayashi M, Hall MN (2014) Making new contacts: the mTOR network in metabolism and signaling crosstalk. Nat Rev Mol Cell Biol 15:155–162
Sies H (2015) Oxidative stress: a concept in redox biology and medicine. Redox Biol 4:180–183
Siska PJ, Beckermann KE, Mason FM, Andrejeva G, Greenplate AR, Sendor AB et al (2017) Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight 2:e93411
Sliger B, Ritz U, Ferrone S (2006) Molecular mechanism of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer 118:129–138
Smale ST (2011) Hierarchies of NF-κB target-gene regulation. Nat Immunol 12:689–694
Smith WM, Purvis IJ, Bomstad CN, Labak CM, Velpula KK, Tsung AJ, Regan JN, Venkataraman S, Vibhakar R, Asuthkar S (2019) Therapeutic targeting of immune checkpoints with small molecule inhibitors. Am J Transl Res 11:529–541
Smith-Garvin JE, Koretzky GA, Jordan MS (2009) T cell activation. Annu Rev Immunol 27:591–619
Somoza C, Lanier LL (1995) T-cell costimulation via CD28-CD86 and CD40-CD40 ligand interactions. Res Immunol 146:171–176
Stanford SM, Rapini N, Bottini N (2012) Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity. Immunol 137:1–19
Sucher R, Fischler K, Oberhuber R, Kronberger I, Margreiter C, Ollinger R et al (2012) DO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated ag-4 Ig-mediated long-term solid organ allograft survival. J Immunol 188:37–46
Sugiura A, Rathmell JC (2018) Metabolic barriers to T cell function in tumors. J Immunol 200:400–407
Sun Y, Lu Y, Saredy J, Wang X, Drummer Iv C, Shao Y et al (2020a) ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes. Redox Biol 37:101696. 21 pages
Sun L, Wang X, Saredy J, Yuan Z, Yang X (2020b) Innate-adaptive immunity interplay and redox regulation in immune response. Redox Biol 37:101759. 13 pages
Sun L, Yang X, Yuan Z, Wang H (2020c) Metabolic reprogramming in immune response and tissue inflammation. Arterioscler Thromb Vasc Biol 40:1990–2001
Suthanthiran M, Anderson ME, Sharma VK, Meister A (1990) Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci U S A 87:3343–3347
Syn NL, Teng MW, Mok TS, Soo RA (2017) De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol 18:e731–e741
Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516–2522
Thompson ED, Enriquez HL, Fu YX, Engelhard VH (2010) Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J Exp Med 207:1791–1804
Thorén FB, Betten A, Romero AI, Hellstrand K (2007) Cutting edge: antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis. J Immunol 179:21–25
Tsou P, Katayama H, Ostrin EJ, Hanash S (2016) The emerging role of B cells in tumor immunity. Cancer Res 76:5597–5601
Tu K, Li J, Mo H, **an Y, Xu Q, **ao X (2021) Identification and validation of redox–immune based prognostic signature for hepatocellular carcinoma. Int J Med Sci 18:2030–2041
Tundo GR, Sbardella D, Lacal PM, Graziani G, Marini S (2019) On the horizon: targeting next generation immune checkpoints for cancer treatment. Chemotherapy 64:62–80
Turpaev K, Glatigny A, Bignon J, Delacroix H, Drapier JC (2010) Variation in gene expression profiles of human monocytic U937 cells exposed to various fluxes of nitric oxide. Free Radic Biol Med 48:298–305
Uribe-Querol E, Rosales C (2015) Neutrophils in cancer: two sides of the same coin. J Immunol Res 2015:983698, 21 pages
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84
Varn FS, Wang Y, Mullins DW, Fiering S, Cheng C (2017) Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment. Cancer Res 77:1271–1282
Vaupel P, Mayer A (2016) Hypoxia-driven adenosine accumulation: a crucial microenvironmental factor promoting tumor progression. Adv Exp Med Biol 876:177–183. New York, NY: Springer New York
Velmurugan R, Challa DK, Ram S, Ober RJ, Ward ES (2016) Macrophage-mediated trogocytosis leads to death of antibody-opsonized tumor cells. Mol Cancer Ther 15:1879–1889
Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8:523–532
Vlachostergios PJ, Oikonomou KG, Gibilaro E, Apergis G (2015) Elevated lactic acid is a negative prognostic factor in metastatic lung cancer. Cancer Biomark 15:725–734
Wang R, Green DR (2012) Metabolic checkpoints in activated T cells. Nat Immunol 13:907–915
Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8:761–773
Watanabe N, Nakajima H (2012) Coinhibitory molecules in autoimmune diseases. Clin Dev Immunol 2012:269756. 7 pages
Watanabe M, Fujihara C, Radtke AJ, Chiang YJ, Bhatia S, Germain RN et al (2017) Co-stimulatory function in primary germinal center responses: Cd40 and b7 are required on distinct antigen-presenting cells. J Exp Med 214:2795–2810
Weinberg SE, Singer BD, Steinert EM, Martinez CA, Mehta MM, Martinez-Reyes I et al (2019) Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature 565:495–503
Weiskopf K, Weissman IL (2015) Macrophages are critical effectors of antibody therapies for cancer. MAbs 7:303–310
Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G et al (1993) Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett 321:89–92
Wenes M, Shang M, Matteo MD, Govera J, Martin-Perez R et al (2016) Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis. Cell Metab 24:701–715
Werlenius O, Aurelius J, Hallner A, Akhiani AA, Simpanen M et al (2016) Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells. Oncotarget 7:32046–32053
Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ et al (1990) Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. J Biol Chem 265:3189–3192
Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1989) Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler 370:1063–1069
Wheeler ML, Defranco AL (1950) Prolonged production of reactive oxygen species in response to b cell receptor stimulation promotes B cell activation and proliferation. J Immunol 189:4405–4416
Widner B, Werner ER, Schennach H, Wachter H, Fuchs D (1997) Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424–2426
Wing K, Sakaguchi S (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11:7–13
Wingren AG, Parra E, Varga M, Kalland T, Sjogren HO, Hedlund G et al (1995) T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 15:235–253
Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP et al (2011) Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 89:873–891
Witztum JL, Lichtman AH (2014) The influence of innate and adaptive immune responses on atherosclerosis. Ann Rev Pathol 9:73–102
Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124:315–327
Wu S, Lu H, Bai Y (2019) Nrf2 in cancers: a double-edged sword. Cancer Med 8:2252–2267
Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496:445–455
**a C, Rao X, Zhong J (2017) Role of t lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res 2017:6494795. 6 pages
**ng F, Hu Q, Qin Y, Xu J, Zhang B, Yu X, Wang W (2022) The relationship of redox with hallmarks of cancer: the importance of homeostasis and context. Front Oncol 12:862743
Yan Z, Garg SK, Kipnis J, Banerjee R (2009) Extracellular redox modulation by regulatory T cells. Nat Chem Biol 5:721–723
Yang Y (2015) Cancer immunotherapy harnessing the immune system to battle cancer. J Clin Invest 125:3335–3337
Yang J, Zhang L, Yu C, Yang XF, Wang H (2014) Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2:1. 9 pages
Yang J, Fang P, Yu D, Zhang L, Zhang D, Jiang X (2016) Chronic kidney disease induces inflammatory cd40+ monocyte differentiation via homocysteine elevation and DNA hypomethylation. Circ Res 119:1226–1241
Yi J, Jung J, Hong SW, Lee JY, Han D, Kim KS et al (2019) Unregulated antigen presenting cell activation by t cells breaks self tolerance. Proc Natl Acad Sci U S A 116:1007–1016
Youn JI, Gabrilovich DI (2010) The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40:2969–2975
Yuen GJ, Demissie E, Pillai S (2017) B lymphocytes and cancer: a love-hate relationship. Trends Cancer 2:747–757
Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AHM, Ballimer-Hofer K, Schwendener RA (2006) Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95:272–281
Zhang C, **n H, Zhang W, Yazaki PJ, Zhang Z et al (2016) CD5 binds to interleukin-6 and induces a feed-forward loop with the transcription factor STAT3 in B cells to promote cancer. Immunity 44:913–923
Zhou F (2010) Perforin: more than just a pore-forming protein. Int Rev Immunol 29:56–76
Zinkernagel RM, Doherty PC (1997) The discovery of MHC restriction. Immunol Today 18:14–17
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bansal, M.P. (2023). Immune System, Redox Signaling, and Cancer Immunity. In: Redox Regulation and Therapeutic Approaches in Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-99-7342-2_6
Download citation
DOI: https://doi.org/10.1007/978-981-99-7342-2_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-7341-5
Online ISBN: 978-981-99-7342-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)